▶ 調査レポート

光線力学療法の世界市場:製品別、用途別、エンドユーザー別

• 英文タイトル:Photodynamic Therapy Market (Product: Drugs [Porphyrin Derivative (PD), Aminolevulinic Acid (ALA), Chlorines, Others], Devices [Disposable Fiber Optic Light Delivery Devices (DFOLDD), Diode Lasers]; Application: Cancer [Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer, Others], Actinic Keratosis (AK), Psoriasis, Acne, Others; End User: Hospitals, Cosmetics & Dermatology Clinics, Cancer Treatment Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。光線力学療法の世界市場:製品別、用途別、エンドユーザー別 / Photodynamic Therapy Market (Product: Drugs [Porphyrin Derivative (PD), Aminolevulinic Acid (ALA), Chlorines, Others], Devices [Disposable Fiber Optic Light Delivery Devices (DFOLDD), Diode Lasers]; Application: Cancer [Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer, Others], Actinic Keratosis (AK), Psoriasis, Acne, Others; End User: Hospitals, Cosmetics & Dermatology Clinics, Cancer Treatment Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN074資料のイメージです。• レポートコード:TPM-2JN074
• 出版社/出版日:Transparency Market Research / 2019年11月26日
• レポート形態:英文、PDF、243ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥608,475 (USD5,795)▷ お問い合わせ
  Multi User¥923,475 (USD8,795)▷ お問い合わせ
  Corporate License¥1,238,475 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは光線力学療法の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、用途別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。
・序論
・仮定・研究方法
・エグゼクティブサマリー
・市場状況
・市場動向
・光線力学療法の世界市場:製品別
・光線力学療法の世界市場:用途別
・光線力学療法の世界市場:エンドユーザー別
・光線力学療法の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)
・光線力学療法の北米市場分析・予測
・光線力学療法の欧州市場分析・予測
・光線力学療法のアジア太平洋市場分析・予測
・光線力学療法の中南米市場分析・予測
・光線力学療法の中東・アフリカ市場分析・予測
・競争状況

New discoveries in photodynamic therapy (PDT) are benefitting cancer patients. As such, it has been found that, PDT is effective in treating multidrug-resistant breast cancer. Dysfunctional DNA repair genes and abnormal signal transduction are some of the major complications associated with breast cancer resistance. Hence, companies in the photodynamic therapy market are becoming increasingly aware about the complications of breast cancer resistance, and increasing the availability of PDT in hospitals and cancer treatment centers.

Cancer is projected to account for the highest revenue amongst all applications in the photodynamic therapy market, with an estimated value of ~US$ 2.3 billion by the end of 2023. This is why, healthcare companies are increasing awareness about PDT amongst breast cancer resistant patients. As such, PDT is being used as an alternative to broad-spectrum antibiotics-based therapy, thus minimizing the incidence of drug resistance. Companies are also increasing R&D to assess PDT-resistant cells to further study the impact of PDT on cellular targets. Healthcare providers are increasing their efficacy in PDT technology to achieve therapeutic relevance in appropriate photosensitizer (PS) level with its retention in the target tissue.

Growing incidence of actinic keratosis (AK) have led to innovations in the photodynamic therapy market. Dermoscopy serves as a useful tool for monitoring skin lesions during PDT and follow-up. Healthcare providers in the photodynamic therapy landscape are treating actinic keratosis (AK) patients with aminolevulinic acid (ALA) drugs. ALA agents are increasingly gaining popularity, and are anticipated to account for the highest revenue amongst all drugs in the photodynamic therapy market, with a projected value of ~US$ 4 billion by the end of 2027. Thus, healthcare providers in hospitals and dermatology clinics are offering topical ALA-PDT, since the treatment is widely approved by health commissions across various countries.

Dermoscopic monitoring is being used in tandem with PDT, and serves as a valuable and non-invasive technique, not just for diagnosing AK but also other serious skin diseases. The technique of dermoscopy is very useful for healthcare providers, since it can visualize the morphological structures of the inner layers of the skin that are not visible to the naked eye. Thus, dermoscopy is boosting the growth of the photodynamic therapy market.

Healthcare providers in the photodynamic therapy market are adopting new strategies to achieve enhanced clinical translation. They are using the approach of customized protocols for the treatment of cancer and other infectious diseases. Companies are developing improved formulations of porphyrin-derivative (PD) compounds. This trend is projected to grow during the forecast period, since PD is projected to account for the second-highest revenue amongst all drugs in the photodynamic therapy market, with an estimated value of ~US$ 3 billion by the end of 2027. Hence, companies are developing intelligent PD molecules that can target specific cells and offer efficient drug delivery.

Companies in the photodynamic therapy market are developing strategies to improve transdermal ALA delivery. They are utilizing high-power CO2 lasers to produce microhole grating. Companies are increasing the production of ALA creams, since the grating procedure is followed by the application of the cream, assisted by ultrasound, to enhance the cream’s penetration into the holes. Another approach, such as the use of a soluble microneedle patch, helps in continuous delivery of ALA until the material is completely dissolved inside the lesion.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Epidemiology of Skin Disorders and Cancer

5.2. Major Companies in Global Photodynamic Therapy Market

5.3. Regulatory Scenario Assessment

5.4. Technological Advancements

5.5. Major Diseases Treated through Photodynamic Therapy

5.6. Patent Landscape Summary

6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

6.2.1. Drugs

6.2.1.1. Porphyrin Derivative (PD)

6.2.1.1.1. Hematoporphyrin Derivative (HpD)

6.2.1.1.2. Benzoporphyrin Derivative (BPD)

6.2.1.1.3. Texaphyrins

6.2.1.1.4. Others

6.2.1.2. Aminolevulinic acid (ALA)

6.2.1.3. Chlorines

6.2.1.4. Others

6.2.2. Devices

6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

6.2.2.2. Diode Laser

6.3. Global Photodynamic Therapy Market Attractiveness, by Product

7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application

7.1. Introduction

7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

7.2.1. Cancer

7.2.1.1. Basal Cell Carcinoma

7.2.1.2. Non-small Cell Lung Cancer

7.2.1.3. Head & Neck Cancer

7.2.1.4. Others

7.2.2. Actinic Keratosis (AK)

7.2.3. Psoriasis

7.2.4. Acne

7.2.5. Others

7.3. Global Photodynamic Therapy Market Attractiveness, by Application

8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user

8.1. Introduction

8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

8.2.1. Hospitals

8.2.2. Cosmetics & Dermatology Clinics

8.2.3. Cancer Treatment Centers

8.2.4. Others

8.3. Global Photodynamic Therapy Market Attractiveness, by End-user

9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region

9.1. Introduction

9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Photodynamic Therapy Market Attractiveness, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast

10.1. Introduction

10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

10.2.1. Drugs

10.2.1.1. Porphyrin Derivative (PD)

10.2.1.1.1. Hematoporphyrin Derivative (HpD)

10.2.1.1.2. Benzoporphyrin Derivative (BPD)

10.2.1.1.3. Texaphyrins

10.2.1.1.4. Others

10.2.1.2. Aminolevulinic Acid (ALA)

10.2.1.3. Chlorines

10.2.1.4. Others

10.2.2. Devices

10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

10.2.2.2. Diode Laser

10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

10.3.1. Cancer

10.3.1.1. Basal Cell Carcinoma

10.3.1.2. Non-small Cell Lung Cancer

10.3.1.3. Head & Neck Cancer

10.3.1.4. Others

10.3.2. Actinic Keratosis (AK)

10.3.3. Psoriasis

10.3.4. Acne

10.3.5. Others

10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Cosmetics & Dermatology Clinics

10.4.3. Cancer Treatment Centers

10.4.4. Others

10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Photodynamic Therapy Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Application

10.6.3. By End-user

10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast

11.1. Introduction

11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

11.2.1. Drugs

11.2.1.1. Porphyrin Derivative (PD)

11.2.1.1.1. Hematoporphyrin Derivative (HpD)

11.2.1.1.2. Benzoporphyrin Derivative (BPD)

11.2.1.1.3. Texaphyrins

11.2.1.1.4. Others

11.2.1.2. Aminolevulinic Acid (ALA)

11.2.1.3. Chlorines

11.2.1.4. Others

11.2.2. Devices

11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

11.2.2.2. Diode Laser

11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

11.3.1. Cancer

11.3.1.1. Basal Cell Carcinoma

11.3.1.2. Non-small Cell Lung Cancer

11.3.1.3. Head & Neck Cancer

11.3.1.4. Others

11.3.2. Actinic Keratosis (AK)

11.3.3. Psoriasis

11.3.4. Acne

11.3.5. Others

11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Cosmetics & Dermatology Clinics

11.4.3. Cancer Treatment Centers

11.4.4. Others

11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Photodynamic Therapy Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Application

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

12.2.1. Drugs

12.2.1.1. Porphyrin Derivative (PD)

12.2.1.1.1. Hematoporphyrin Derivative (HpD)

12.2.1.1.2. Benzoporphyrin Derivative (BPD)

12.2.1.1.3. Texaphyrins

12.2.1.1.4. Others

12.2.1.2. Aminolevulinic Acid (ALA)

12.2.1.3. Chlorines

12.2.1.4. Others

12.2.2. Devices

12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

12.2.2.2. Diode Laser

12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

12.3.1. Cancer

12.3.1.1. Basal Cell Carcinoma

12.3.1.2. Non-small Cell Lung Cancer

12.3.1.3. Head & Neck Cancer

12.3.1.4. Others

12.3.2. Actinic Keratosis (AK)

12.3.3. Psoriasis

12.3.4. Acne

12.3.5. Others

12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Cosmetics & Dermatology Clinics

12.4.3. Cancer Treatment Centers

12.4.4. Others

12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Application

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

13.2.1. Drugs

13.2.1.1. Porphyrin Derivative (PD)

13.2.1.1.1. Hematoporphyrin Derivative (HpD)

13.2.1.1.2. Benzoporphyrin Derivative (BPD)

13.2.1.1.3. Texaphyrins

13.2.1.1.4. Others

13.2.1.2. Aminolevulinic Acid (ALA)

13.2.1.3. Chlorines

13.2.1.4. Others

13.2.2. Devices

13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

13.2.2.2. Diode Laser

13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

13.3.1. Cancer

13.3.1.1. Basal Cell Carcinoma

13.3.1.2. Non-small Cell Lung Cancer

13.3.1.3. Head & Neck Cancer

13.3.1.4. Others

13.3.2. Actinic Keratosis (AK)

13.3.3. Psoriasis

13.3.4. Acne

13.3.5. Others

13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Cosmetics & Dermatology Clinics

13.4.3. Cancer Treatment Centers

13.4.4. Others

13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Application

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

14.2.1. Drugs

14.2.1.1. Porphyrin Derivative (PD)

14.2.1.1.1. Hematoporphyrin Derivative (HpD)

14.2.1.1.2. Benzoporphyrin Derivative (BPD)

14.2.1.1.3. Texaphyrins

14.2.1.1.4. Others

14.2.1.2. Aminolevulinic Acid (ALA)

14.2.1.3. Chlorines

14.2.1.4. Others

14.2.2. Devices

14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

14.2.2.2. Diode Laser

14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

14.3.1. Cancer

14.3.1.1. Basal Cell Carcinoma

14.3.1.2. Non-small Cell Lung Cancer

14.3.1.3. Head & Neck Cancer

14.3.1.4. Others

14.3.2. Actinic Keratosis (AK)

14.3.3. Psoriasis

14.3.4. Acne

14.3.5. Others

14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

14.4.1. Hospitals

14.4.2. Cosmetics & Dermatology Clinics

14.4.3. Cancer Treatment Centers

14.4.4. Others

14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Application

14.6.3. By End-user

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)

15.2. Company Profiles

15.2.1. Biofrontera AG

15.2.1.1. Company Description

15.2.1.2. Business Overview

15.2.1.3. Financial Overview

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Theralase Technologies Inc.

15.2.2.1. Company Description

15.2.2.2. Business Overview

15.2.2.3. Financial Overview

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. LUMIBIRD

15.2.3.1. Company Description

15.2.3.2. Business Overview

15.2.3.3. SWOT Analysis

15.2.4. Quest PharmaTech Inc.

15.2.4.1. Company Description

15.2.4.2. Business Overview

15.2.4.3. Financial Overview

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Modulight, Inc.

15.2.5.1. Company Description

15.2.5.2. Business Overview

15.2.5.3. Strategic Overview

15.2.5.4. SWOT Analysis

15.2.6. Galderma Laboratories L.P. (Nestlé)

15.2.6.1. Company Description

15.2.6.2. Business Overview

15.2.6.3. Financial Overview

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. Sun Pharmaceutical Industries Ltd.

15.2.7.1. Company Description

15.2.7.2. Business Overview

15.2.7.3. Financial Overview

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. SUS Advancing Technology Co., Ltd

15.2.8.1. Company Description

15.2.8.2. Business Overview

15.2.8.3. SWOT Analysis

List of Tables

Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027